Page last updated: 2024-11-05

zardaverine and Carcinoma, Squamous Cell

zardaverine has been researched along with Carcinoma, Squamous Cell in 1 studies

zardaverine: structure given in first source
zardaverine : A pyridazinone derivative in which pyridazin-3(2H)-one is substituted at C-6 with a 4-(difluoromethoxy)-3-methoxyphenyl group. It is a phosphodiesterase inhibitor, selective for PDE3 and 4.

Carcinoma, Squamous Cell: A carcinoma derived from stratified SQUAMOUS EPITHELIAL CELLS. It may also occur in sites where glandular or columnar epithelium is normally present. (From Stedman, 25th ed)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fryknäs, M1
Rickardson, L1
Wickström, M1
Dhar, S1
Lövborg, H1
Gullbo, J1
Nygren, P1
Gustafsson, MG1
Isaksson, A1
Larsson, R1

Other Studies

1 other study available for zardaverine and Carcinoma, Squamous Cell

ArticleYear
Phenotype-based screening of mechanistically annotated compounds in combination with gene expression and pathway analysis identifies candidate drug targets in a human squamous carcinoma cell model.
    Journal of biomolecular screening, 2006, Volume: 11, Issue:5

    Topics: Carcinoma, Squamous Cell; Caspases; Combinatorial Chemistry Techniques; Drug Evaluation, Preclinical

2006